AVA360 Advertising

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Loading...
18 Views
Published
Swiss drugmaker Novartis gets go-ahead from U.S. regulators to conduct tests of malaria drug against COVID-19.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Sign in or sign up to post comments.
Be the first to comment